ArticleAmerican journal of clinical and experimental immunology2021

Assessment of fingolimod versus dimethyl fumarate for the treatment of multiple sclerosis; a 24-month follow-up study.

Samane-Sadat Masjedi et al.PubMed ↗Full text ↗

No numbers read from the abstract.